Glycemic Control and Adverse Clinical Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus: Results from KNOW-CKD

Background: The optimal level of glycosylated hemoglobin (HbA1c) to prevent adverse clinical outcomes is unknown in patients with chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM). Methods: We analyzed 707 patients with CKD G1-G5 without kidney replacement therapy and T2DM from the Ko...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes & metabolism journal 2023-07, Vol.47 (4), p.535
Hauptverfasser:	Ga Young Heo, Hee Byung Koh, Hyung Woo Kim, Jung Tak Park, Tae-hyun Yoo, Shin-wook Kang, Jayoun Kim, Soo Wan Kim, Yeong Hoon Kim, Su Ah Sung, Kook-hwan Oh, Seung Hyeok Han
Format:	Artikel
Sprache:	kor
Schlagworte:	Cardiovascular diseases chronic Diabetes mellitus Glycated hemoglobin A Renal insufficiency type 2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!